ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,027.84
-0.16%
Dow Jones
37,923.23
0.28%
US Dollar vs MXN
17.0637
-0.52%
Brent Oil
85.175
-0.84%
Bitcoin
57,263.80
-5.50%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) Noticias

NAOV NanoVibronix Inc

0.7196
-0.0154 (-2.10%)
Pre Mercado
Última actualización: 08:18:34
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NanoVibronix Inc NAOV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0154 -2.10% 0.7196 08:18:34
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.735
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:00BWNanoVibronix Announces PainShield Will Be Included in..
09/4/202407:30BWNanoVibronix Issues Letter to Stockholders
28/3/202407:30BWNanoVibronix Signs Agreement for Research and Development of..
26/2/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202414:45EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/1/202415:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202415:30EDGAR2Form 8-K - Current report
11/12/202315:30EDGAR2Form 8-K - Current report
06/12/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:00BWNanoVibronix Featured in Your Bladder Health Magazine
04/12/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:45EDGAR2Form 8-K - Current report
04/12/202308:00BWNanoVibronix Enters into Letter of Intent with APOGEPHA..
28/11/202308:00EDGAR2Form 8-K - Current report
28/11/202308:00BWNanoVibronix Announces Agreement for Clinical Study of..
21/11/202307:30EDGAR2Form 8-K - Current report
21/11/202307:30BWNanoVibronix Regains Nasdaq Compliance
14/11/202307:30BWNanoVibronix Issues Letter to Shareholders
13/11/202315:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202307:30EDGAR2Form 8-K - Current report
07/11/202307:30BWNanoVibronix UroShield Products Available on NHS Drug Tariff..
27/9/202307:00EDGAR2Form 8-K - Current report
27/9/202307:00BWNanoVibronix Gains Approval for Inclusion of UroShield..
21/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202309:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/9/202309:25EDGAR2Form RW - Registration Withdrawal Request
12/9/202315:15EDGAR2Form S-3 - Registration statement under Securities Act of..
06/9/202307:30EDGAR2Form 8-K - Current report
06/9/202307:30BWNanoVibronix Announces Presentation of Positive Independent..
01/9/202315:30EDGAR2Form 8-K - Current report
30/8/202313:29BWNanoVibronix Announces $5 Million Private Placement Priced..
30/8/202307:30EDGAR2Form 8-K - Current report
30/8/202307:30BWNanoVibronix Cites Positive Results from Independent Testing..
29/8/202315:05EDGAR2Form 8-K - Current report
29/8/202315:05BWNanoVibronix Responds to CMS’ Determination for PainShield
28/8/202307:30EDGAR2Form 8-K - Current report
28/8/202307:30BWNanoVibronix Applies for Inclusion of UroShield Products in..
23/8/202315:45EDGAR2Form 8-K - Current report
23/8/202307:45BWNanoVibronix Extends Distribution Agreement with Its Largest..
11/8/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202316:14EDGAR2Form S-1/A - General form for registration of securities..
01/8/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
20/7/202315:45EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
NAOV
NanoVibronix
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados